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Neuro-inflammation plays an important role in the recovery of brain injury after stroke.
Microglia/macrophage is the major executor in the neuro-inflammation, which can be
polarized into two distinct phenotypes: injurious/toxic classical activation (M1 phenotype)
and protective alternative activation (M2 phenotype). Here, we investigated whether
intracerebral administration of interleukin-4 (IL-4) at an early stage could affect the
activation of microglia/macrophage and the corresponding outcome after intracerebral
hemorrhage (ICH). The neuro-behavior was recorded between different groups in the
rat ICH model. The M1 and M2 markers were then determined by qRT-PCR, western
blotting, ELISA, and immunofluorescence, respectively. We observed aberrant activation
of microglia/macrophage after ICH. After intracerebral injection of IL-4, M1 activation was
greatly inhibited while M2 activation was enhanced, along with improving neurobehavioral
recovery from deficits after ICH. Our study showed that early intracerebral injection of
IL-4 potentially promotes neuro-functional recovery, probably through enhancing the
alternative activation of microglia/macrophage.
Keywords: stroke, intracerebral hemorrhage, interleukin-4(IL-4), microglia/macrophage, recovery, M1 phenotype,
M2 phenotype
INTRODUCTION
Intracerebral hemorrhage (ICH) accounts for 15% of strokes, which is a lethal neurological disease
(Qureshi et al., 2001; Mehndiratta et al., 2012). Treatment with ICH generally involves a surgical
procedure to remove the hematoma, with varying and controversial efficiencies and prognosis. Due
to the poor prognosis of ICH coupled with the extensive burden on the family of patients and
society, exploring new ways to improve the clinical outcome of ICH is necessary. Recent studies
showed that neuro-inflammation deeply relates to the progression of ICH-induced brain injury
(Wang and Tsirka, 2005; Mracsko and Veltkamp, 2014). Progressive brain loss after stroke could
be prevented and the clinical outcome could be improved by modulating the immune milieu after
ICH (Wang et al., 2007).
Microglia/Macrophage plays a critical role in innate immune in CNS, which has two cell
types: injurious/toxic classically activated microglia/macrophage (M1) and protective alternatively
activated microglia/macrophage (M2) (Gordon, 2003; Martinez et al., 2008; Kigerl et al., 2009;
Tang et al., 2014). Classically activated cells could produce reactive oxygen species (ROS) and
pro-inflammatory cytokines which are cytotoxic, while alternatively activated cells could release
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anti-inflammatory cytokines and neurotrophic factors, which
show the characteristics of wound-healing by blocking pro-
inflammatory response (Banati et al., 1993; Kigerl et al., 2009).
These two activating statuses have opposite roles during the
repair after CNS damage. Manipulating the activation status
of the microglia/macrophage may be a promising strategy to
improve the outcome after ICH.
Recently, Interleukin-4 (IL-4) cytokines has been
demonstrated to effectively induce protective M2 cell subtype
activation, which associated with tissue repair and composition
of extracellular matrix (Gordon, 2003; Colton and Wilcock,
2010; Graeber, 2010). Also, pretreatment by IL-4, prevented,
in a dose-dependent manner, neuronal cell injury induced by
activated microglia (Chao et al., 1993). Here, in the rat ICH
model, we focus on whether IL-4 could improve the outcome
by modulation of inflammatory milieu and its influence on
microglia/macrophage polarization after administration of IL-4.
MATERIALS AND METHODS
Animal Groups and ICH Model
A total of 167 adult male Sprague Dawley (SD) rats that weighed
250–300 g were randomly allocated to four groups: Control
group (n = 12), ICH group (n = 73), ICH + PBS group
(vehicle group, n = 41), and ICH + IL-4 group (n = 41).
In detail, each time point has six rats in qRT-PCR experiment.
Each group has eight rats in behavior recovery test experiment
and each group has three rats in western blotting, ELISA, and
immunofluorescence. The ICH model was induced by intra-
striatal injection of collagenase IV as previously described (Lu
et al., 2014; Chen M. et al., 2015). Briefly, we performed rat
anesthesia with intraperitoneal injection of 10% chloralhydrate
(0.4ml/kg) which diluted in water. Then, the rats were fixed with
stereotaxic frame (KOPF, California, USA), the bregma exposed
and drilled a pin hole located on right lateral 3mm away from
bregma. The needle was inserted into striatum (5mm depth from
skull pin hole) controlled with stereotaxic frame. One microliter
collagenase IV (0.25 IU/µl) (Sigma; C5138) was slowly injected,
which was controlled by micro-injector lasting for 5min. Animal
Care Committee of the Wenzhou Medical University approved
the procedures involving animals. All surgeries were performed
under chloralhydrate anesthesia, for minimizing suffering.
Drug Injection
The IL-4 (PeproTech Asia, # 400-04) was dissolved in PBS
and stored at −20◦C. IL-4 (0.8µl each, final concentration
is 0.25µg/µl) was orthotropic intracranially injected 1 h post
collagenase IV injection. The injection of IL-4 was controlled by
stereotaxic frame and micro-injector. The injection coordinate
is the same as that of collagenase IV injection. For control, the
ICH+PBS group (vehicle group) has been injected with same
volume of PBS (0.8µl).
Gene Expression
The striatum were separated from rat brains and the total mRNA
was then isolated from striatum with Trizol (Thermo Fisher,
15596-026). RevertAid TM First Strand cDNA Synthesis Kit
(Thermo Fisher, K1622) was used to reverse transcribe 1µg
of total mRNA to cDNA. Then, SYBR Green Realtime PCR
Master Mix-Plus (TOYOBO, QPK 212) was used to perform
qRT-PCR. Primers used in qRT-PCR reactions were synthesized
by Invitrogen (Shanghai, China) (Table 1). The fold change of
gene expression was calculated using the 2−11Ct algorithm.
Western Blot Analysis and Enzyme-Linked
Immunosorbent Assay (ELISA)
Before the surgery, the rats were anesthetized with 10%
chloralhydrate. Then, we separated striatum from rat brains
on ice. Each striatum was homogenized in RIPA lysis buffer
(Thermo, USA) with the addition of protease inhibitor. The
homogenate was centrifuged for 15min at 12,000 rpm, 4◦C. The
protein concentrations were detected by Pierce™ BCA Protein
Assay Kit (Thermo Scientific, # 23225). Fifty micrograms of
total proteins were loaded onto 8% SDS-PAGE gel. Proteins
were transferred onto polyvinylidene difluoride filters (PVDF)
membranes, followed by blocking with 5% milk for 1 h at
room temperature. Then, specific primary antibodies against
iNOS (Rabbit; Abcam; ab3523; 1:3, 000); Arg 1 (Rabbit;
Abcam; ab91279; 1:1, 000); and tubulin β (Rabbit; Bioworld
Technology; BS1482; 1:1, 000) were incubated overnight at
4◦C. After the incubation with secondary antibodies for 1 h,
we used ECL (Thermo Scientific; PI32109) to visualize bands,
which were then analyzed by the Quantity One (Bio-Rad;
Version 4.6.2).
Also, we used ELISA kits (R&D Systems, USA) to detect the
cytokines in the striatal protein extract including IL-1β, TNF-α,
IL-6, and IL-13, according to the manual instruction.
Immunofluorescence
The rats were anesthetized at day 3 after ICH. Trans-cardiac
perfusion has been performed with 4% paraformaldehyde,
followed by dehydration with 30% sucrose for 48 h. Coronal
frozen sections (10µm) were then harvested from the striatum.
Brain sections were incubated overnight with primary antibodies:
iNOS (Rabbit; Abcam; ab3523; 1:100); Arg 1 (Rabbit; Abcam;
ab91279; 1:100); and Iba 1 (Goat; Abcam; ab5076; 1:200)
at 4◦C. Then, the slices were incubated at 37◦C for 1 h
with secondary antibodies: Fluor 594-conjugated (Donkey anti-
Rabbit; Invitrogen; A-21207; 1: 500) and Fluor 488-conjugated
TABLE 1 | Primers used in qRT-PCR reactions.
Gene Forward primer(5′-3′) Reverse primer (5′-3′)
iNOS AAGCTGCATGTGACTCCATC TGCAAGAGATATCCGAGGTG
TNF-α GCGTGTTCATCCGTTCTCTACC TACTTCAGCGTCTCGTGTGTTTCT
IL-1β TACAAGGAGAGACAAGCAACGACA TTCCATCTTCTTCTTTGGGTATTG
IL-13 CCACAGGACCCAGAGGATATTGA TAGCGGAAAAGTTGCTTGGAGTAA
IL-6 AGACTTCACAGAGGATACCACCCAC CAATCAGAATTGCCATTGCACAA
Arg 1 CATATCTGCCAAGGACATCG ATTCCCAGCTTGTCCACTTC
Ym 1 GGAGTAGAGACCATGGCACTGAAC GACTTGCGTGACTATGAAGCATTG
CD206 TCTTTGCCTTTCCCAGTCTCC TGACACCCAGCGGAATTTC
GAPDH CTGGCATTGCTCTCAATGACAAC CTTGCTCTCAGTATCCTTGCTG
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(Donkey anti-Goat; Invitrogen; A-11058; 1: 500). Furthermore,
sections were stained with DAPI (Roche; 10236276001; 1:20,
000). Images were acquired by using scanning fluorescence
microscope (Leica Microsystems). For statistical analysis, we
selected 6 slices for staining from each brain (n = 3 for
each group). Six to ten digital microscopic images around the
hematoma region were randomly applied in each slice. Double
positive cell number was quantified and the average of sections
from each brain was taken. The size of the image was measured
by scanning fluorescence microscope. Results were expressed as
the average number of cells per mm2.
Behavior Examination
The assessment of the modified Neurological Severity Scores
(mNSS) including sensory, motor, reflex, and balance tests is a
complex behavior test (Schallert et al., 1997; Mahmood et al.,
2013). The maximum score of the test is 18, which means
maximum deficit. The rats had been trained and assessed prior to
FIGURE 1 | M1 and M2 microglia/macrophage activation in the striatum after intracerebral hemorrhage (ICH). Real-time RT-PCR results showed
time-course changes in M1 activation-related genes (A–D,I). qRT-PCR results showed time-course changes in M2 activation-related genes (E–H,J). *P < 0.05;
**P < 0.01 (n = 6).
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FIGURE 2 | IL-4 improves the recovery of neurobehavioral function
after ICH. The neurobehavior was evaluated by mNSS after ICH between
different groups. *P < 0.05; **P < 0.01 (n = 8).
surgery, to make sure the basal score is 0. Then, blind behavioral
deficit tests were performed at 1, 3, 7, and 14 days after ICH,
respectively.
Statistical Analysis
Data were presented as mean ± SEM. Two-way analysis of
variance (ANOVA) and Bonferroni post-tests were used to
analyze the behavior data. The gene expression, western blotting,
ELISA, and immunofluorescence data were analyzed by One-way
ANOVA and Bonferroni post-tests. The results were considered
statistically significant when P-value < 0.05. The statistical
analysis was performed by GraphPad Prism 5 (San Diego, CA,
USA).
RESULTS
The M1/M2 Cell Subtype Activation During
the Acute Inflammation After ICH
In order to study the activation of M1/M2 cells after ICH, total
mRNA was isolated and purified from striatum. qRT-PCR was
then performed to respectively test M1 biomarkers (such as
iNOS, IL-1β, TNF-α, and IL-6) and M2 biomarkers (such as IL-
13, Arg 1, Ym 1, and CD206). For M1 makers, we found that the
expression level of iNOS (P < 0.01; n = 6) was significantly
increased at 1 day post ICH (Figure 1A), while those of IL-1β
(P < 0.05; n = 6), TNF-α (P < 0.05; n = 6), and IL-6 (P < 0.01;
n = 6) were increased at 3 h post ICH (Figures 1B–D). For M2
markers, the levels of Arg 1 (P < 0.01; n = 6), IL-13 (P < 0.01;
n = 6), YM 1 (P < 0.01; n = 6), and CD206 (P < 0.05;
n = 6) were all increased at 1 day post ICH (Figures 1E–H).
The results showed that the M1 activation was rapidly increased
at 3 h, peaked at 1 day, and quenched to the normal about
3 days after ICH (Figure 1I). Whereas, the M2 activation was
increased at 1 day, which was later than M1 activation, and
returned after about 7 days (Figure 1J). In summary, after ICH,
both M1 and M2 subtypes are significant activated, while M2
activation is occurred later than M1, but persisted for a long
time.
IL-4 Improved the Function Recovery of
ICH Rat
Then, we studied whether the administration of IL-4 could
influence neurobehavioral function recovery in ICH model rats.
We used the mNSS scale to evaluate neurobehavioral function
between different groups. The rats were trained prior to surgery
to ensure the basal level (score = 0). Then, the rat behavior
score was evaluated and record at each time point post ICH. The
evaluation process was blinded. We performed two-way analysis
of variance (ANOVA) and Bonferroni post-tests to analyze the
result of the behavior test. We found that there were significant
differences between the ICH+IL-4 group and the ICH+PBS
group at 3 (P < 0.05; n = 8), 7 (P < 0.01; n = 8), and 14
days (P < 0.01; n = 8) after ICH (Figure 2). Moreover, there
was no significant difference between the ICH+PBS group and
the ICH group (Figure 2). The results suggested that injection
of IL-4 significantly improved the outcome of ICH model
rats.
IL-4 Decreased the Activation of M1 Cells
After ICH
After we observed that IL-4 injection significantly improved the
functional recovery, we explored the possible mechanism of IL-4
influences on the outcome of ICH. We performed western blot
and ELISA to detect the expression levels of M1 markers. The
results showed that iNOS (P < 0.05; n = 3), IL-1β (P < 0.05;
n = 3), IL-6 (P < 0.05; n = 3), and TNF α (P < 0.05;
n = 3) were downregulated at 1 day after administration of
IL-4 (Figures 3A–D), which were compared to the ICH+PBS
group. Furthermore, at tissue level, we co-stained brain slices
with iNOS/Iba 1. We found that IL-4 could significantly decrease
the iNOS+/Iba 1+ cells (P < 0.05; n = 3) surrounding the
hematoma at 3 days after ICH (Figure 4). All above, the results
indicated that the activation of M1 cells has been inhibited after
IL-4 administration.
IL-4 Increased the Activation of M2 Cells
After ICH
On the other hand, we also explored whether IL-4 influenced the
activation of M2 cells. The M2 activation post IL-4 injection was
investigated with western blot, ELISA and immunofluorescence,
respectively. We found that IL-4 significantly induced Arg
1 expression (P < 0.01; n = 3) at 1 day after ICH
(Figure 3A). Besides, ELISA results showed that injection of
IL-4 enhanced the production of IL-13 (P < 0.01; n = 3)
at 1 day after ICH (Figure 3E). In addition, at tissue level,
the co-staining Arg 1/Iba 1 showed that Arg 1+/Iba 1+ cells
(P < 0.01; n = 3) had been significantly increased in
the ICH+IL-4 group (Figure 5) compare to ICH+PBS group
at 3 days after ICH. These results demonstrated that IL-
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FIGURE 3 | IL-4 inhibits M1 activation and promotes M2 activation. The protein level of M1 and M2 markers has been detected by western blot (A) and ELISA
(B–E) at 1 day after ICH. *P < 0.05; **P < 0.01; ***P < 0.001 (n = 3).
4 treatment could enhance the activation of M2 cell type
after ICH.
DISCUSSION
In this study, we observed the dynamic activation of
microglia/macrophage during the acute inflammation after
ICH. Early intracerebral injection of IL-4 could improve the
recovery of ICH rat. In addition, administration of IL-4 could
change the polarization of microglia/macrophage by inhibiting
M1 activation and inducing M2 activation.
Recent studies demonstrated that immune responses play an
important role in the brains injury after stroke (Dirnagl et al.,
1999; Xie et al., 2014; Yang et al., 2015). For innate immune, when
encountering insulting stimulations, microglia/macrophage was
activated (Zhang et al., 2001). Consistently, our study showed
that the microglia/macrophage was significantly activated after
ICH. Specifically, we found that the expression levels of M1
markers (IL-1β, TNF-α, and IL-6; Mosser and Edwards, 2008;
Kumar et al., 2013; Tang and Le, 2016) rapidly increased at 3 h,
peaked at 1 day, and returned to normal levels after about 3
days, whereas those of M2 markers (Arg 1, IL-13, YM 1, and
CD206) (Kumar et al., 2013; Mosser and Edwards, 2008; Tang
and Le, 2016) increased at 1 day after ICH and returned after
about 7 days. The profile of M1/M2 changes is similar with
that of the cutaneous wound model, performed by Deonarine
et al. (2007) They found that both of M1 and M2 markers
increased at day 2, with M2 markers increased consistently at
day 4 and 8 during the healing of cutaneous wound (Deonarine
et al., 2007). In addition, recent studies demonstrated that
microglia/macrophage activation was detected as early as 1 h
following ICH in the collagenase injection model and within
4 h using whole blood injection (Xue and Del, 2000; Wang and
Doré, 2007). In spinal cord injury, traumatic brain injury and
ischemic injury, M2 type transiently detected at high levels before
7 days, however, M1 type maintained even up to 28 dpi (Hu et al.,
2012; Chen Y. J. et al., 2015; Kumar et al., 2015). The profile of
microglia/macrophage activation was also positively associated
with the severity of the model.
Evidence showed that IL-4 plays critical roles in learning
and memory in the normal brain (Derecki et al., 2010). In
addition, IL-4 has been demonstrated to protect the brain from
injury in the ischemic model (Xiong et al., 2011; Hu et al.,
2015). Administration of IL-4 at the acute phase of ICH in this
study could significantly improve neuro-behavior recovery in
ICH rat model. However, further studies are needed to test the
protective effects of IL-4 for fully elucidate the optimal time point
and dose.
Interleukin-4 (IL-4) is a multifunctional cytokine, which
could influence Th2 subset differentiation and polarization of
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FIGURE 4 | IL-4 decreased iNOS+/Iba 1+ cells. Compared with ICH group, iNOS+/Iba 1+ (A,B) cells had significant decreased in the ICH+IL-4 group at at 3
days after ICH. Arrows indicate iNOS+/Iba 1+ cells. Rat ICH model brain coronal section slice (C). The region between the red and white cycle indicates the area
around hematoma, where take images. Scale bar = 50µm. *P < 0.05; **P < 0.01 (n = 3).
microglia/macrophage (Kato and Nariuchi, 2000; Kobayashi
et al., 2013; Orihuela et al., 2016). Recent research points to
a dual role of microglia/macrophage in neuronal injury and
recovery in stroke. In addition, microglia/macrophage own
two phenotypes (M1/M2), which plays opposite roles during
the repair after CNS damage (Kigerl et al., 2009). The M2
type is related to wound healing and tissue repair can secret
protective cytokines, while the M1 type involves in the pro-
inflammation response exacerbate neuronal demise (Banati et al.,
1993). Furthermore, the M1 type cells have been shown to
impair axon regrowth (Kigerl et al., 2009), while M2 polarization
has been shown to be essential for efficient remyelination
(Miron et al., 2013). In the present research, administration
of IL-4 at early stage after ICH decreased M1 activation,
while enhanced M2 activation. Besides, IL-4 inhibited the
secretion of M1-related cytokines (IL-6, IL-1β, and TNF α),
while promoted the production of M2-related cytokines (IL-13).
Thus, IL-4 modulate immune responses after ICH through
changing the activation phenotypes of microglia/macrophage,
which may partially account for the recovery of ICH rat by IL-4
administration.
However, for clinical application, there are still some issues
need to figure out. The recombinant proteins still have some
limitations as therapeutic agents (Leader et al., 2008). Also, the
therapeutic window and the delivery method of the IL-4 still need
to be further studied.
In conclusion, our study showed that microglia/macrophage
was activated after ICH. Administration of IL-4 could improve
the functional recovery of ICH. Early injection of IL-4 could
promote anti-inflammatory response which favors the repair via
inhibiting M1 cell activation while enhance M2 cell activation
after ICH. Therefore, administration of IL-4 in the early phase
of ICH is likely to be one promising therapeutic approach for
improve the outcome of ICH.
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FIGURE 5 | IL-4 increased Arg 1+/Iba 1+ cells. Compared with ICH group, Arg 1+/Iba 1+ (A,B) cells had significant increased at the ICH+IL-4 group at at 3 days
after ICH. Arrows indicate Arg 1+/Iba 1+ cells. Scale bar = 50µm. **P < 0.01 (n = 3).
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